What can we help you find?

Leading the way in transplantation

Filter results for:

Crossing the bridge: tailoring antiviral prophylaxis by linking it to CMV-specific immunity

Start Date:
Monday, September 07th 2020 at 18:00
End Date:
Monday, September 07th 2020 at 19:00
Country:
online
Description & Objectives:

By attending this webinar, participants will learn, why CMV-specific immunity is so important for the long term outcome of patients, and how one can support the patient’s immune system to build such CMV-specific immunity.

Target Group:

Healthcare professionals involved with transplantation, particularly those who are involved in heart and/or lung transplantation

Chaired by: Fausto Baldanti, Pavia, Italy; Martina Sester, Hamburg, Germany

CMV-specific immunity monitoring: how, when and why? (Lionel Couzi, Bordeaux, France)

All patients are different and some of them are experiencing problems regarding their CMV despite prophylaxis

  • What are the available ways to evaluate CMV immunity?
  • At which time point could it be interesting to look at it?
  • Why should we take into account CMV-specific immunity?

Designing tailored CMV-specific immunity? (Javier Carbone, Madrid, Spain)

  • Antiviral prophylaxis switch of the virus
  • Patients need to come in contact with CMV – the immune system needs to learn how to deal with CMV
  • How can this be achieved?
    • mTor inhibitors / everolimus
    • CMVIG
      • leaving the patients less unprotected ? binding + neutralizing free virus
      • supporting the patient’s immune system to mount a lasting response (cross-presentation, T cell responses, B cell responses)
  • Improved clinical CMV management protocols

How to register

Register here

Event supporters

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.